MENU
+Compare
MIST
Stock ticker: NASDAQ
AS OF
Apr 2 closing price
Price
$0.80
Change
+$0.04 (+5.26%)
Capitalization
42.85M

MIST Milestone Pharmaceuticals Forecast, Technical & Fundamental Analysis

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications... Show more

MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MIST with price predictions
Apr 02, 2025

MIST's RSI Indicator sits in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MIST advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

MIST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MIST as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MIST turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

MIST moved below its 50-day moving average on March 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MIST crossed bearishly below the 50-day moving average on March 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.259) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (74.074) is also within normal values, averaging (252.036).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MIST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MIST is expected to report earnings to rise 15.79% to -21 cents per share on May 19

Milestone Pharmaceuticals MIST Stock Earnings Reports
Q1'25
Est.
$-0.22
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.05
The last earnings report on March 13 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 2.54M shares outstanding, the current market capitalization sits at 42.85M.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HOWL0.910.04
+4.81%
Werewolf Therapeutics
BNTC12.550.53
+4.41%
Benitec Biopharma
BNS47.520.65
+1.39%
Bank of Nova Scotia
RMBS52.680.39
+0.75%
Rambus
LTC35.32-0.23
-0.65%
LTC Properties

MIST and Stocks

Correlation & Price change

A.I.dvisor tells us that MIST and AKBA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and AKBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+5.67%
AKBA - MIST
33%
Poorly correlated
+1.05%
GYRE - MIST
29%
Poorly correlated
+10.61%
PRAX - MIST
29%
Poorly correlated
+3.46%
OSRH - MIST
29%
Poorly correlated
-14.53%
ADAP - MIST
28%
Poorly correlated
+22.00%
More